168 related articles for article (PubMed ID: 11785702)
1. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.
Lin W; Cormier M; Samiee A; Griffin A; Johnson B; Teng CL; Hardee GE; Daddona PE
Pharm Res; 2001 Dec; 18(12):1789-93. PubMed ID: 11785702
[No Abstract] [Full Text] [Related]
2. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.
Matriano JA; Cormier M; Johnson J; Young WA; Buttery M; Nyam K; Daddona PE
Pharm Res; 2002 Jan; 19(1):63-70. PubMed ID: 11837701
[TBL] [Abstract][Full Text] [Related]
3. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of desmopressin using a coated microneedle array patch system.
Cormier M; Johnson B; Ameri M; Nyam K; Libiran L; Zhang DD; Daddona P
J Control Release; 2004 Jul; 97(3):503-11. PubMed ID: 15212882
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of antisense oligonucleotides.
Brand RM; Iversen PL
Methods Mol Med; 2005; 106():255-69. PubMed ID: 15375321
[No Abstract] [Full Text] [Related]
6. Topical and transdermal delivery of antisense oligonucleotides.
Brand RM
Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
[TBL] [Abstract][Full Text] [Related]
7. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
Ita K
Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of antisense compounds.
Brand RM; Iversen PL
Adv Drug Deliv Rev; 2000 Oct; 44(1):51-7. PubMed ID: 11035197
[TBL] [Abstract][Full Text] [Related]
9. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
10. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
11. Aspects of the transport and delivery of antisense oligonucleotides.
Juliano RL; Yoo H
Curr Opin Mol Ther; 2000 Jun; 2(3):297-303. PubMed ID: 11249624
[TBL] [Abstract][Full Text] [Related]
12. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
Weyermann J; Lochmann D; Georgens C; Zimmer A
Eur J Pharm Biopharm; 2005 Apr; 59(3):431-8. PubMed ID: 15760723
[TBL] [Abstract][Full Text] [Related]
13. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.
Juliano RL; Alahari S; Yoo H; Kole R; Cho M
Pharm Res; 1999 Apr; 16(4):494-502. PubMed ID: 10227702
[TBL] [Abstract][Full Text] [Related]
14. Microinjection of antisense oligonucleotides to assess G-protein subunit function.
Kleuss C; Schultz G; Wittig B
Methods Enzymol; 1994; 237():345-55. PubMed ID: 7935009
[No Abstract] [Full Text] [Related]
15. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis.
Tezel A; Dokka S; Kelly S; Hardee GE; Mitragotri S
Pharm Res; 2004 Dec; 21(12):2219-25. PubMed ID: 15648253
[TBL] [Abstract][Full Text] [Related]
16. Delivery is key: lessons learnt from developing splice-switching antisense therapies.
Godfrey C; Desviat LR; Smedsrød B; Piétri-Rouxel F; Denti MA; Disterer P; Lorain S; Nogales-Gadea G; Sardone V; Anwar R; El Andaloussi S; Lehto T; Khoo B; Brolin C; van Roon-Mom WM; Goyenvalle A; Aartsma-Rus A; Arechavala-Gomeza V
EMBO Mol Med; 2017 May; 9(5):545-557. PubMed ID: 28289078
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide treatments for psoriasis.
White PJ; Atley LM; Wraight CJ
Expert Opin Biol Ther; 2004 Jan; 4(1):75-81. PubMed ID: 14680470
[TBL] [Abstract][Full Text] [Related]
18. [Antisense c-fos oligonucleotides-induced myopia in guinea pigs].
Liu SZ; Wei X; Wang JY; Wu XY; Tan XP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):132-7. PubMed ID: 17344603
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of enhancers for transdermal drug delivery.
Mitragotri S
Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
